This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Genetic Disorders  • Neurogenetics  • Pediatric Neurology  • Neurology, Other  • Pediatrics  • Congenital Malformations  • Alert me on articles by topic

Effect of Clinical, Neuroradiological, and Modern Genetic Classification

Marie Claire Yvette de Wit, MD; Maarten H. Lequin, MD, PhD; Ireneaus F. M. de Coo, MD, PhD; Esther Brusse, MD; Dicky J. J. Halley, PhD; Raoul van de Graaf, BSc; Rachel Schot, BSc; Frans W. Verheijen, PhD; Grazia M. S. Mancini, MD, PhD

Arch Neurol. 2008;65(3):358-366.

Background  Malformations of cortical development (MCDs) are a major source of handicap. Much progress in understanding the genetic causes has been made recently. The number of affected children in whom a molecularly confirmed diagnosis can be made is unclear.

Objective  To evaluate the etiology of MCDs in children and the effect of a combined radiological, clinical, and syndrome classification.

Design  A case series of 113 children with a radiological diagnosis of MCD from January 1, 1992, to January 1, 2006.

Setting  The Erasmus Medical Center–Sophia Children's Hospital, a secondary and tertiary referral center.

Patients  Patients with MCD underwent a complete radiological, clinical, and neurological assessment and testing for known genes involved in the pathogenesis of MCD as appropriate for their phenotype.

Results  We established an etiological diagnosis in 45 of 113 cases (40%). For 21 patients (19%), this included molecular and/or genetic confirmation (Miller-Dieker syndrome; LIS1, DCX, FLNA, EIF2AK3, or KIAA1279 mutations; or an inborn error of metabolism). In 17 (15%), a syndrome with an unknown genetic defect was diagnosed. In 7 patients (6%), we found evidence of a gestational insult. Of the remaining 68 patients, 34 probably have a yet-unknown genetic disorder based on the presence of multiple congenital anomalies (15 patients), a family history with multiple affected persons (12 patients), or consanguineous parents (7 patients).

Conclusions  In our cohort, combining diagnostic molecular testing with clinical, radiological, and genetic classification; syndrome identification; and family study provided a diagnosis in 40% of the cases of MCD. This contributes to the possibility of prenatal diagnosis and improved patient treatment and disease management.

Author Affiliations: Departments of Pediatric Neurology (Drs de Wit, de Coo, and Brusse), Pediatric Neuroradiology (Dr Lequin), and Clinical Genetics (Drs Halley, Verheijen, and Mancini; Mr van de Graaf; and Ms Schot), Erasmus Medical Center–Sophia Children's Hospital, Rotterdam, the Netherlands.